NCT00826657

Brief Summary

We hope to learn the clinical and functional signs of sub-clinical vitamin B12 deficiency and its response to supplementation in non-anemic, non-pregnant, and non-lactating women in Rural Mexico. Vitamin B12 is important in hematopoiesis, neuro-cognitive functions and genetic integrity. However vitamin B12 is only found in animal source foods therefore a large segment of the population in developing countries and those practicing vegetarianism are at risk of deficiency of the vitamin. This information will help decide weather supplementation with vitamin B12 is necessary in such populations for public health reasons.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
180

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2004

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 1, 2004

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2005

Completed
1.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2006

Completed
2.2 years until next milestone

First Submitted

Initial submission to the registry

January 16, 2009

Completed
6 days until next milestone

First Posted

Study publicly available on registry

January 22, 2009

Completed
Last Updated

May 21, 2015

Status Verified

May 1, 2015

Enrollment Period

10 months

First QC Date

January 16, 2009

Last Update Submit

May 19, 2015

Conditions

Keywords

B12 deficiencymethylmalonic acidhomocysteinvitamin B12 supplementation intervention

Outcome Measures

Primary Outcomes (1)

  • response to B12 supplementation in serum B12, Methylmalonic acid, homocystein, and holotranscobalamin concentrations

    0 and 3 mos

Secondary Outcomes (1)

  • DNA methylation change, and hematological response to B12 supplementation

    0 and 3 mos

Study Arms (2)

placebo

PLACEBO COMPARATOR

Receive placebo (sugar pill) during the intervention. Received a 1000 mg vitamin B12 injection at the end of the study.

Dietary Supplement: placebo

Vitamin B12

ACTIVE COMPARATOR

Received 500 micrograms vitamin B12 per day during the study Received a 1000 mg vitamin B12 injection at the start of the study

Dietary Supplement: Vitamin B12

Interventions

Vitamin B12DIETARY_SUPPLEMENT

500 microgram daily supplement of vitamin B12 1000 mg injection vitamin B12 given at the start of the study

Vitamin B12
placeboDIETARY_SUPPLEMENT

placebo given as a daily supplement 1000 mg injection of vitamin B12 given at the end of the study

Also known as: sugar pill
placebo

Eligibility Criteria

Age20 Years - 59 Years
Sexfemale
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Women age 20-59, apparently healthy, no severe B12 deficiency

You may not qualify if:

  • pregnancy, lactation, anemia and disease states

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universidad Autonoma de Queretaro

Querétaro, Mexico

Location

Related Publications (1)

  • Shahab-Ferdows S, Anaya-Loyola MA, Vergara-Castaneda H, Rosado JL, Keyes WR, Newman JW, Miller JW, Allen LH. Vitamin B-12 supplementation of rural Mexican women changes biochemical vitamin B-12 status indicators but does not affect hematology or a bone turnover marker. J Nutr. 2012 Oct;142(10):1881-7. doi: 10.3945/jn.112.165712. Epub 2012 Aug 22.

MeSH Terms

Conditions

Vitamin B 12 Deficiency

Interventions

Vitamin B 12Sugars

Condition Hierarchy (Ancestors)

Vitamin B DeficiencyAvitaminosisDeficiency DiseasesMalnutritionNutrition DisordersNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

CorrinoidsTetrapyrrolesPyrrolesAzolesHeterocyclic Compounds, 1-RingHeterocyclic CompoundsHeterocyclic Compounds, 4 or More RingsHeterocyclic Compounds, Fused-RingMacrocyclic CompoundsPolycyclic CompoundsCarbohydrates

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 16, 2009

First Posted

January 22, 2009

Study Start

October 1, 2004

Primary Completion

August 1, 2005

Study Completion

November 1, 2006

Last Updated

May 21, 2015

Record last verified: 2015-05

Locations